1. Seremetis S, Aledort LM, Bona R et al. (1992) A three-year randomized prospective study of high or intermediate purity factor VIII concentrates in asymptomatic HIV+ hemophiliacs: effects on immune function. Blood 80 [Suppl 1]:366a
2. De Biasi R, Rocino A, Miraglia E, Mastrullo L, Quirino AA (1992) The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate. Blood 78: 1919–1922
3. De Biasi R, Rocino A (1992) The impact of very-high-purity, monoclonally purified factor VIII concentrates on the immune system of HIV-positive hemophiliacs. World Federation of Hemophilia Congress Abstracts, p220
4. Mannucci PM, Gringeri A, De Biasi R, Baudo F, Morfini M, Ciavarella N (1992) Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate. Thromb Haemost 67: 310–313
5. Mannucci PM, Abildgaard CF, Aledort LM et al. (1992): Immunologic studies in HIV-positive and HIV-negative hemophiliacs receiving recombinant factor VIII (Kogenate) — a 3-year update. Blood 80 [Suppl 1]:230a